St. Jude’s Liz Kellogg, Ph.D., uses cryo-EM to study programmable transposons for targeted gene therapies, including potential new treatments for cystic fibrosis.
St. Jude is forging a new frontier in gene editing for cystic fibrosis
Posted in bioengineering, biotech/medical